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Aim.Thismeta-analysiswasperformedtoevaluatetheassociationbetweenACEI/DgenepolymorphismandMCNSsusceptibility.
Method. A predeﬁned literature search and selection of eligible relevant studies were performed to collect the data from electronic
databases. Results. Six articles were identiﬁed for the analysis of association between ACE I/D gene polymorphism and MCNS
risk, including 4 for Asians, one in Caucasian population and one for Africans. There was a markedly positive association between
D allele or DD genotype and MCNS susceptibility in Asians (D: P = .01, DD: P = .02), but not for Caucasians and Africans
(Caucasians: D: P = .16, DD: P = .98; Africans: D: P = .81, DD: P = .49). Furthermore, the II genotype seemed not to
play a protective role against MCNS risk for Asians, Caucasians and Africans (P = .12, P = .09, P = .76, resp.). Interestingly,
there was also signiﬁcant association between ACE I/D gene polymorphism and MCNS susceptibility in overall populations (D:
P = .007, DD: P = .04, II: P = .03). Conclusion. D allele or DD genotype might be a signiﬁcant genetic molecular marker for
MCNS susceptibility in Asians and overall populations, but not for Caucasians and Africans. More larger and rigorous genetic
epidemiological investigations are required to further explore this association.
1.Introduction
Minimal change nephrotic syndrome (MCNS) is one of the
most important histopathological characteristics in patients
with idiopathic nephrotic syndrome (INS), and long-term
outcome of most of the patients with this disease is
favorable [1]. Some investigations suggested that genetic
factors might play a key role in the pathomechanism of
MCNS [2–5]. The angiotensin-converting enzyme (ACE)
insertion/deletion (I/D) gene polymorphism, correlating
with circulating and cellular ACE concentration, might take
part in the etiology of MCNS and have been investigated
in numerous epidemiologic studies at present. However,
the available evidence reported to date is weak, due to
sparseness of data or disagreements among studies. There is
raremeta-analysistoexploretheassociationofACEI/Dgene
polymorphism with MCNS risk. We performed this meta-
analysis to investigate the association between ACE I/D gene
polymorphism and MCNS susceptibility, with the intention
to provide a much more reliable ﬁnding on the signiﬁcance
of the association.
2.MaterialsandMethods
2.1. Search Strategy. The relevant studies were screened from
the search engines of PubMed, Cochrane Library, and CBM-
disc (China Biological Medicine Database) on September
1, 2010. (Minimal change nephrotic syndrome OR MCNS)
AND (Angiotensin converting enzyme OR ACE) was used
in PubMed, Cochrane Library, and CBM-disc. The search
in PubMed was limited to humans. We also extended search
spectrum to the “related articles” and the bibliographies of
all retrieved studies. If multiple publications from the same
study group occurred, we only recruited the most complete
paper for analysis.2 International Journal of Nephrology
Table 1: Characteristics of the studies evaluating the eﬀects of ACE genes on MCNS risk.
First author, year Ethnicity
Case Control D allele (%)
DD ID II DD ID II Case Control
Lee 1997 [8] Asian 9 25 21 9 25 27 39.10 35.25
Al-Eisa 2001 [9] Asian 16 5 1 25 22 1 84.09 75.00
Sasongko 2005 [10] Asian 4 26 39 6 21 41 24.63 24.26
Serdaroglu 2005 [11] Asian 36 27 10 99 124 64 67.81 56.10
Sasse 2006 [7] Caucasian 5 12 0 58 91 50 64.71 52.01
Saber-Ayad 2010 [6] African 0 5 0 10 34 6 50.00 54.00
2.2. Inclusion and Exclusion Criteria
2.2.1. Inclusion Criteria. (1) A case-control study, (2) the
outcomehadtobeMCNS,and(3)therehadtobeatleasttwo
comparison groups (MCNS group versus control group).
2.2.2.ExclusionCriteria. (1)Reviewarticles;(2)casereports;
(3) articles did not provide the detail genotype data; (4)
investigated the association of other genes with MCNS.
2.3. Data Extraction and Synthesis. The following informa-
tion was extracted from each study independently by at least
2 investigators: ﬁrst author’s surname, year of publication,
ethnicity of study population, and the number of cases
and controls for ACE genotypes. Frequencies of alleles
were calculated for case group and control group, from
the corresponding genotype distribution. The results were
compared and disagreements were resolved by discussion.
2.4. Statistical Analysis. Available data was entered into
Cochrane Review Manager (RevMan, version 5) and ana-
lyzed. The pooled statistic was counted using the ﬁxed eﬀects
model, but a random eﬀects model was conducted when the
P value of heterogeneity test was less than .1. Results were
expressed with odds ratios (OR) for dichotomous data, and
95% conﬁdence intervals (CI) were also calculated. P<. 05
was required for the overall OR to be deemed statistically
signiﬁcant. I2 was used to test the heterogeneity between
the included studies. All descriptive data were expressed as
mean ± SD.
3. Results
3.1. Study Characteristics. The search yielded 46 references,
38 in Pubmed, 0 from Cochrane Library and 7 in CBM-disc,
and one study [6] was included from the “related articles”
and the bibliographies of all retrieved studies. According to
the inclusion and exclusion criteria, six studies [6–11]w e r e
identiﬁed for the meta-analysis of the association between
ACE I/D gene polymorphism and MCNS susceptibility in
our ﬁnal review. Four studies [8–11]w e r ec o n d u c t e di n
Asians, one investigation [7] for Caucasians and one [6]
in Africans. All the studies were published in English. The
data of our interest were extracted: ﬁrst author’s surname,
year of publication, ethnicity of study population, and the
number of cases and controls for ACE genotypes (Table 1).
These six studies contained 241 case series and 713 controls.
The average distribution frequency of ACE D allele in
Asian patients with MCNS was 53.91%, and the frequency
in controls was 47.65%. The average distribution of D
allele frequency in Caucasians was 64.71% in cases and
52.01% for controls. Furthermore, the average distribution
frequency of D allele in Africans with MCNS was 50.00%,
and the frequency in control group was 54.00%. The ratio of
cases/controls for average distribution frequency of D allele
in Caucasians was slightly elevated when compared with
those in Asians and Africans (Asians: MCNS/control = 1.13;
Caucasians: MCNS/control = 1.24; Africans: MCNS/control
= 0.93).
3.2. Association of the ACE I/D Gene Polymorphism with
MCNS Risk. In this meta-analysis, we found there was a
signiﬁcant association between D allele or DD genotype
and risk of MCNS in overall populations (P = .007, P =
.04; Table 2). The ﬁxed eﬀects OR estimated for the MCNS
susceptibility was 1.39 in D allele patients when compared
with patients carrying I allele (95% CI: 1.09–1.76), with
evidence of between-study heterogeneity (P = .64; Table 2).
Furthermore, the ﬁxed eﬀect OR estimated for the risk of
developing MCNS was 1.46 in DD homozygous patients
compared with both other genes combined (95% CI: 1.01–
2.11), for the reason that the P value of heterogeneity test
was .45. We also documented there was notable association
between the II genotype and the risk of MCNS relative to
both other genotypes combined (OR = 0.65, 95% CI: 0.44–
0.96, P = .03, Table 2).
In our study, we found that the average frequency of D
allele in control group of Africans was a little elevation when
compared with those in Asians and Caucasians (Africans:
54.00%; Asians: 47.65%; Caucasians: 52.01%). True race-
speciﬁc genetic eﬀects might aﬀect the results of our
analysis for the association of ACE I/D gene polymorphism
with the onset of MCNS. In order to evaluate the race-
speciﬁc eﬀect, we divided the population by ethnicity. In
Asians, we found that the association of D allele or DD
genotypewithMCNSsusceptibility waspositively signiﬁcantInternational Journal of Nephrology 3
Table 2: Meta analysis of the association of ACE I/D gene polymorphism with MCNS risk.
Genetic contrasts Group and subgroups Studies number Q test P value Model OR (95% CI) P
Dv e r s u sI
Overall 6 .64 Fixed 1.39 (1.09,1.76) .007
Asian 4 .46 Fixed 1.38 (1.07,1.79) .01
Caucasian 1 — Fixed 1.69 (0.81,3.51) .16
Africa 1 — Fixed 0.85 (0.23,3.13) .81
DD versus (DI + II)
Overall 6 .45 Fixed 1.46 (1.01,2.11) .04
Asian 4 .36 Fixed 1.60 (1.07,2.38) .02
Caucasian 1 — Fixed 1.01 (0.34,3.00) .98
Africa 1 — Fixed 0.35 (0.02,6.86) .49
II versus (DI + DD)
Overall 6 .58 Fixed 0.65 (0.44,0.96) .03
Asian 4 .70 Fixed 0.73 (0.49,1.09) .12
Caucasian 1 — Fixed 0.08 (0.00,1.43) .09
Africa 1 — Fixed 0.62 (0.03,12.62) .76
Study or subgroup
Al-Eisa 2001
Lee 1997
Sasongko 2005
Serdaroglu 2005
Total (95% CI)
Total events
Events
37
43
34
99
213
Total
44
110
138
146
438
Events
72
43
33
322
470
Total
96
122
136
574
928
Weight
7.3%
25.1%
25.3%
42.4%
100%
M-H, ﬁxed, 95% CI
1.76 [0.69, 4.47]
1.18 [0.69, 2.01]
1.02 [0.59, 1.77]
1.65 [1.12, 2.42]
1.38 [1.07, 1.79]
Case Control Odds ratio Odds ratio
M-H, ﬁxed, 95% CI
0.01 0.1 1 10 100
Favours case Favours control Test for overall eﬀect: Z = 2.44 (P = .01)
Heterogeneity: χ2 = 2.57, df = 3( P = .46); I2 = 0%
Figure 1: Relationship between D allele and MCNS risk in Asians.
Study or subgroup
Al-Eisa 2001
Lee 1997
Sasongko 2005
Serdaroglu 2005
Total (95% CI)
Total events
Events
16
9
4
36
65
Total
22
55
69
73
219
Events
25
9
6
99
139
Total
48
61
68
287
464
Weight
11.4%
19.1%
15.2%
54.3%
100%
M-H, ﬁxed, 95% CI
2.45 [0.82, 7.34]
1.13 [0.41, 3.09]
0.64 [0.17, 2.36]
1.85 [1.10, 3.11]
1.6 [1.07, 2.38]
Case Control Odds ratio Odds ratio
M-H, ﬁxed, 95% CI
0.01 0.1 1 10 100
Favours case Favours control Test for overall eﬀect: Z = 2.29 (P = .02)
Heterogeneity: χ2 = 3.24, df = 3( P = .36); I2 = 7%
Figure 2: Association of DD genotype with MCNS susceptibility in Asians.
(P = .01 and P = .02, resp.) (Table 2, Figures 1 and 2).
However, the II genotype seemed not to play a protective
role against MCNS risk for Asians (OR = 0.73, 95%
CI: 0.49–1.09; P = .12) (Table 2, Figure 3). Interestingly,
there was also no signiﬁcant association between ACE I/D
gene polymorphism and MCNS susceptibility in Caucasian
population and Africans (Caucasian: D: P = .16; DD: P =
.98; II: P = .09; Africans: D: P = .81; DD: P = .49; II:
P = .76) (Table 2).
4. Discussion
There is increasing evidence suggesting that the rennin-
angiotensin system (RAS) has been a well-documented
participation in the pathogenesis of renal disease. Genetic
markers, in particular ACE I/D gene polymorphism, might
oﬀer some beneﬁts to better predict the outcome of renal
diseases. The level of plasma ACE, constitutively expressed
in several types of somatic cells, is linked to an I/D4 International Journal of Nephrology
Study or subgroup
Al-Eisa 2001
Lee 1997
Sasongko 2005
Serdaroglu 2005
Total (95% CI)
Total events
Events
1
21
39
10
71
Total
22
55
69
73
219
Events
1
27
41
64
133
Total
48
61
68
287
464
Weight
1.1%
27.9%
31.6%
39.4%
100%
M-H, ﬁxed, 95% CI
2.24 [0.13, 37.52]
0.78 [0.37, 1.63]
0.86 [0.43, 1.69]
0.55 [0.27, 1.14]
0.73 [0.49, 1.09]
Case Control Odds ratio Odds ratio
M-H, ﬁxed, 95% CI
0.01 0.1 1 10 100
Favours case Favours control Test for overall eﬀect: Z = 1.53 (P = .12)
Heterogeneity: χ2 = 1.41, df = 3( P = .7); I2 = 0%
Figure 3: Association between II homozygous and risk of MCNS in Asians.
gene polymorphism of 287bp in intron 16 of the ACE
gene [7, 12]. The D allele and DD genotype has been
reported to be associated with higher plasma ACE level
[13]. ACE is a key enzyme of RAS that can convert inactive
angiotensin I into a vasoactive and aldosterone-stimulating
peptide angiotensin II [14, 15]. The elevation of ACE
protein expression might be responsible for the elevation
of plasma angiotensin II level [16]. Increased angiotensin
II level makes deleterious actions on renal hemodynamics
and induces the protein expression of some other growth
factors, leading to glomerulosclerosis [17, 18]. MCNS, an
important histopathological characteristic of INS, is one of
the most common acquired renal diseases. Data on the risk
factors for poor prognosis and the pathogenesis of MCNS
are insuﬃcient. Furthermore, ﬁndings on the association
of ACE I/D gene polymorphism with MCNS susceptibility
have been controversial since the ﬁrst investigation was
reported. In order to draw a more convincing conclusion,
this meta-analysis was performed to explore the associ-
ation between ACE I/D gene polymorphism and MCNS
risk.
In this investigation, six studies were recruited into
our meta-analysis, four studies in Asians, one investigation
for Caucasian population and one in Africans. In order
to achieve a satisfactory power, meta-analysis of multiple
studies clearly has a role in oﬀering an association with such
potentials. In our meta-analysis for overall populations, we
found the association between D allele or DD homozygous
and the risk of MCNS was statistically signiﬁcant, and
the II genotype seemed to play a protective factor against
MCNS risk. However, the disequilibrium of gene distribu-
tions among Asians, Caucasians, and Africans in healthy
controls was observed in our study, which might aﬀect the
credibility of the conclusion. The average frequency of D
allele in control group for African population was a little
elevation when compared with that in Asians or Caucasians,
suggesting a discrepant role of continental diﬀerences in
gene background and living environment. The results of
overall population might be less powerful and it was diﬃcult
to draw a convincing conclusion. Therefore, the subgroup
analysis was very important in this meta-analysis. In our
subgroup analysis, we found that D allele or DD genotype
was associated with MCNS susceptibility in Asians, but
not for Caucasians and African population. Furthermore, II
genotype seemed not to play a positive role against MCNS
onset for three races. We speculated that D allele or DD
homozygous might sensitively aﬀect MCNS susceptibility in
Asians, but not other two races.
In the included investigations, some studies found the
ACE I/D gene polymorphism might not be associated with
MCNS susceptibility. In Asians, Lee et al. [8] found that
the distribution of ACE genotypes in Korean patients with
MCNS was similar to that in control, and the DD genotype
was more frequent in focal segmental glomerulosclerosis
(FSGS) than in MCNS. Sasongko et al. [10]p e r f o r m e da n
investigation in Javanese-Indonesian patients and found the
ACE genotype frequencies of MCNS patients were consistent
with those of the controls, and D-allele tended to exist more
frequently in FSGS patients than in the MCNS patients and
controls. In Caucasians, the similar results were taken place.
Sasse et al. [7] found there was no signiﬁcant correlation
between ACE genotype and histology of FSGS or MCNS.
Furthermore, in Africans, Saber-Ayad et al. [6] also per-
formed a study on Egyptian children with INS and did not
ﬁndanassociationbetweentheACEI/Dgenepolymorphism
and histological ﬁndings (including MCNS and FSGS). The
results in those studies mentioned above were consistent
with ours for Caucasians and African population, but our
conclusions were inconsistent with those of Asians above.
However, in the other studies for Asian population, the
study of Al-Eisa et al. [9] suggested an association of
the D-allele of the ACE gene I/D polymorphism with the
clinical manifestation of INS in Kuwaiti Arab children, but
they had not calculated the associations of ACE I/D gene
polymorphism with MCNS risk between the controls and
case group, and Serdaroglu et al. [11] found that D allele
frequency was higher in INS group than control group
in Turks and the D allele frequency had no statistically
signiﬁcantdiﬀerencebetweenMCNSgroupandFSGSgroup.
We speculated that the D allele frequency in MCNS group
in the investigation of Serdaroglu et al. might be elevated
when compared with that in controls. The sample number
of the study from Serdaroglu et al. was much larger than
that in other investigations. The conclusion of Serdaroglu
et al. might be more stable when compared with that of
others.International Journal of Nephrology 5
Interestingly, in our investigation, we found the distri-
butions of D allele frequency in control group among four
Asian studies were disequilibrium, ranged from 24.26% to
75.00%. The investigated countries for those studies were
from East Asian to West Asian. In the past years, some
studies found that living environment might inﬂuence the
gene expression [19–22]. We speculated that the living
environment might aﬀect the D allele frequency in controls.
On the other hand, the sample sizes for some studies were
small, which might aﬀect the result for the D allele frequency
in controls. In order to draw a more stable conclusion for
Asians, some investigations following larger sample sizes are
needed in the future.
For Caucasians, The ratio of cases/controls for average
distribution frequency of D allele in Caucasians was 1.24,
which is slightly elevated when compared with those in
Asians and Africans. However, the ACE I/D gene poly-
morphism were not associated with the risk of MCNS in
Caucasians (the analysis for Caucasians only including one
study). More investigations are required to investigate this
relationship for Caucasian population in the future. The
same as that, more studies investigating the association
between ACE I/D gene polymorphism and MCNS suscepti-
bility for African population are required in the future study.
There were some meta-analyses to explore the rela-
tionship between ACE I/D gene polymorphism and the
susceptibility of some diseases in the past years. Zhang
et al. [23] conducted a meta-analysis to investigate the
association of ACE I/D gene polymorphism with asthma
risk and found there was an association between D allele
or DD homozygote and the onset of asthma in Asians but
not for Caucasian population. Ji et al. [24]p e r f o r m e da
meta-analysis to explore the relation between ACE I/D gene
polymorphism and risk of hypertension in Asian population
and found that DD genotype was associated with the onset
of hypertension. Yong et al. [25] and Schena et al. [26],
respectively, took a meta-analysis for the association of ACE
I/D gene polymorphism with susceptibility of immunoglob-
ulin A nephropathy (IgAN) and observed that the DD
homozygous was associated with an increased risk of IgAN
in Asians, but not for Caucasian population. However, there
is rarely a meta-analysis for African population at present.
The conclusions of our investigation were similar to those in
the meta-analyses mentioned above and also found ACE D
allele or DD homozygote was more sensitive for Asians when
compared with other ethnic groups.
5. Limitations
Some limitations should be discussed in this meta-analysis.
First, an important threat to any literature-based review and
meta-analysis is that of reporting bias (we only searched
the published literatures in English or Chinese). Second,
the sample sizes in some studies are relatively small. Last
but not the least, the genotype distributions of the control
population in two included studies [6, 11] did not conform
to Hardy-Weinberg equilibrium test and it might cause bias
in our study. Undoubtedly, the limitations mentioned above
might aﬀect our ﬁnal conclusions.
6. Conclusions
In conclusion, the results in our study supported that DD
genotypeorDallelewasassociatedwithMCNSsusceptibility
in Asians and overall populations, but the association was
not found in Caucasians and Africans. The II homozygous
seemed to play a protective role against MCNS risk in
overallpopulations,buttheassociationsinAsians,Caucasian
population and Africans were not observed. However, more
case-control association investigations on larger, stratiﬁed
populations are required to further clarify the role of this
ACE I/D gene polymorphism in MCNS susceptibility.
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